BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11438460)

  • 1. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.
    Maitra A; Wistuba II; Washington C; Virmani AK; Ashfaq R; Milchgrub S; Gazdar AF; Minna JD
    Am J Pathol; 2001 Jul; 159(1):119-30. PubMed ID: 11438460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
    Acevedo CM; HenrĂ­quez M; Emmert-Buck MR; Chuaqui RF
    Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
    Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
    Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.
    Martinez A; Walker RA; Shaw JA; Dearing SJ; Maher ER; Latif F
    Mol Pathol; 2001 Oct; 54(5):300-6. PubMed ID: 11577171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.
    Hung J; Kishimoto Y; Sugio K; Virmani A; McIntire DD; Minna JD; Gazdar AF
    JAMA; 1995 Feb; 273(7):558-63. PubMed ID: 7837389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 3p alterations in northeastern Thai women with cervical carcinoma.
    Kanjanavirojkul N; Limpaiboon T; Patarapadungkit N; Yuenyao P; Pairojkul C
    Asian Pac J Cancer Prev; 2005; 6(4):501-4. PubMed ID: 16436000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
    Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
    Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
    Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.